EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of TiaoShenGongJian for the Treatment of Breast Cancer

Huiyan Ying, Weikaixin Kong, Xiangwei Xu iD

OncoTargets and Therapy · 2025-01 · Volume 18 · 49-71

DOI: 10.2147/ott.s486300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OncoTargets and Therapy, 2025-01. Verfasst von Huiyan Ying und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Medicine Finland (FIMM), Hilife, University of Helsinki, Helsinki, Finland. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

TiaoShenGongJian (TSGJ) decoction, a traditional Chinese medicine for breast cancer, has unknown active compounds, targets, and mechanisms. This study identifies TSGJ's key targets and compounds for breast cancer treatment through network pharmacology, machine learning, and experimental validation.

Methods

Bioactive components and targets of TSGJ were identified from the TCMSP database, and breast cancer-related targets from GeneCards, PharmGkb, and RNA-seq datasets. Intersection of these targets revealed therapeutic targets of TSGJ. PPI analysis was performed via STRING, and machine learning methods (SVM, RF, GLM, XGBoost) identified key targets, validated by GSE70905, GSE70947, GSE22820, and TCGA-BRCA datasets. Pathway analyses and molecular docking were performed. TSGJ and core compounds' effectiveness was confirmed by MTT and RT-qPCR assays.

Results

160 common targets of TSGJ were identified, with 30 hub targets from PPI analysis. Five predictive targets (HIF1A, CASP8, FOS, EGFR, PPARG) were screened via SVM. Their diagnostic, biomarker, immune, and clinical values were validated. Quercetin, luteolin, and baicalein were identified as core components. Molecular docking confirmed their strong affinities with predicted targets. These compounds modulated key targets and induced cytotoxicity in breast cancer cell lines in a similar way as TSGJ.

Conclusion

This study reveals the main active components and targets of TSGJ against breast cancer, supporting its potential for breast cancer prevention and treatment.

Schlagwörter

Stichwörter der Autor:innen

TiaoShenGongJian decoctionbreast cancermachine learningmolecular mechanismsnetwork pharmacologytraditional Chinese medicine

Autor:innen und Institutionen

  • Institute for Molecular Medicine Finland (FIMM), Hilife, University of Helsinki, Helsinki, Finland.
  • Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, People's Republic of China.
  • Affiliated Yongkang First People's Hospital and School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.

ORCID-Profile: Xiangwei Xu

Zitieren

APA

Ying, H., Kong, W., & Xu, X. (2025). Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of TiaoShenGongJian for the Treatment of Breast Cancer. OncoTargets and Therapy, Volume 18, 49-71. https://doi.org/10.2147/ott.s486300

Vancouver

Ying H, Kong W, Xu X. Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of TiaoShenGongJian for the Treatment of Breast Cancer. OncoTargets and Therapy. 2025;Volume 18:49-71. doi:10.2147/ott.s486300

BibTeX
@article{Ying2025,
  author = {Ying, Huiyan and Kong, Weikaixin and Xu, Xiangwei},
  title = {Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of TiaoShenGongJian for the Treatment of Breast Cancer},
  journal = {OncoTargets and Therapy},
  year = {2025},
  volume = {Volume 18},
  pages = {49--71},
  doi = {10.2147/ott.s486300}
}
Kostenlos starten →